Rizatriptan Benzoate

SOL #: SPE2D2-22-R-0118Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Jul 12, 2022
2
Last Updated
Aug 25, 2022
3
Submission Deadline
Sep 9, 2022, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

This solicitation notice for SPE2D2-22-R-0118 is a replacement for a previously publicized presolicitation notice for SPE2D2-22-R-0009. SPE2D2-22-R-0009 was changed to SPE2D2-22-R-0118 due to a systems issue.

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rizatriptan Benzoate tablets. Procurement details follow.

0001    Rizatriptan  Benzoate Dis Tablets 5 MG – 3 Count bottle

0002    Rizatriptan  Benzoate Dis Tablets 5 MG – 18 Count bottle

0003    Rizatriptan  Benzoate Dis Tablets 10 MG – 3 Count bottle

0004    Rizatriptan  Benzoate Dis Tablets 10 MG – 18 Count bottle

0005    Rizatriptan Benzoate Tablets 5 MG – 12 Count bottle

0006    Rizatriptan Benzoate Tablets 5 MG – 18 Count bottle

0007    Rizatriptan Benzoate Tablets 10 MG – 12 Count bottle

0008    Rizatriptan Benzoate Tablets 10 MG – 18 Count bottle

This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  


A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.gov at https://www.sam.gov. Interested parties should contact Keith Ryales (215-737-9199) (keith.ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is June 2022. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

People

Points of Contact

Keith RyalesPRIMARY
Jason C. WraySECONDARY

Files

Files

Download
Download
Download
Download

Versions

Version 3Viewing
Solicitation
Posted: Aug 25, 2022
Version 2
Solicitation
Posted: Jul 26, 2022
View
Version 1
Solicitation
Posted: Jul 12, 2022
View
Rizatriptan Benzoate | GovScope